Volume 18, Number 2—February 2012
CME ACTIVITY - Research
Declining Guillain-Barré Syndrome after Campylobacteriosis Control, New Zealand, 1988–2010
Michael G. Baker
, Amanda Kvalsvig, Jane Zhang, Rob Lake, Ann Sears, and Nick Wilson
, Amanda Kvalsvig, Jane Zhang, Rob Lake, Ann Sears, and Nick Wilson
Table 4
Distribution of campylobacteriosis and GBS cases, by age, New Zealand, July 1995–December 2008*
| Age group, y | Campylobacteriosis notifications |
Camplyobacteriosis hospitalizations |
GBS hospitalizations |
GBS hospitalizations associated with camplylobacteriosis |
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| No. (%) | Rate‡ | No. (%) | Rate‡ | No. (%) | Rate‡ | No. (%) | Rate‡ | ||||
| <5 | 15,232 (11.7) | 442.5 | 538 (6.4) | 13.9 | 45 (3.4) | 1.2 | 0 | 0 | |||
| 5–9 | 6,295 (4.9) | 176.9 | 200 (2.4) | 5.0 | 33 (2.5) | 0.8 | 2 (5.9) | 0.1 | |||
| 10–19 | 14,481 (11.2) | 203.7 | 965 (11.4) | 12.2 | 113 (8.6) | 1.4 | 3 (8.8) | 0 | |||
| 20–29 | 25,063 (19.3) | 385.9 | 1,509 (17.9) | 20.6 | 115 (8.7) | 1.6 | 1 (2.9) | 0 | |||
| 30–39 | 19,511 (15.0) | 270.7 | 935 (11.1) | 11.5 | 146 (11.1) | 1.8 | 3 (8.8) | 0 | |||
| 40–49 | 16,572 (12.8) | 237.0 | 747 (8.8) | 9.6 | 149 (11.3) | 1.9 | 5 (14.7) | 0.1 | |||
| 50–59 | 14,311 (11.0) | 261.9 | 778 (9.2) | 13.0 | 226 (17.1) | 3.8 | 6 (17.7) | 0.1 | |||
| 60–69 | 9,559 (7.4) | 255.7 | 824 (9.8) | 19.9 | 209 (15.8) | 5.0 | 7 (20.6) | 0.2 | |||
| 70–79 | 6,174 (4.8) | 235.9 | 1,046 (12.4) | 35.9 | 200 (15.2) | 6.9 | 5 (14.7) | 0.2 | |||
| >80 | 2,712 (2.1) | 190.8 | 906 (10.7) | 57.9 | 84 (6.4) | 5.4 | 2 (5.9) | 0.1 | |||
| Total | 129,910 (100.0) | 270.4 | 8,448 (100.0) | 15.8 | 1,320 (100.0) | 2.5 | 34 (100.0) | 0.1 | |||
*GBS, Guillain-Barré syndrome.
†Association with hospitalization for camplylobacteriosis. Includes subsequent and concurrent hospitalizations (campylobacteriosis and GBS diagnoses at time of hospital discharge).
‡Average annual no./100,000 population.
Page created: January 26, 2012
Page updated: January 26, 2012
Page reviewed: January 26, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.